Simultaneously, the knockdown of CTR1 or copper chelation diminishes the expression of glycolytic genes and the utilization of downstream metabolites, impeding hepatocellular carcinoma metabolism (Davis et al., 2020). This evidence concerns the gene SLC31A1 and hepatocellular carcinoma.